Cis/Trans-Isoeugenol

Cis/Trans-Isoeugenol

SCHEMBL3699104

CC=Cc1ccc(O)c(OC)c1.Oc1ccccc1

nearest known ligand 0.81

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TYR P14679 1/20 0.81
▸ TTR P02766 2/20 0.64
▸ CA12 O43570 2/20 0.59
▸ CA4 P22748 2/20 0.59
▸ CA6 P23280 2/20 0.59
▸ CA5A P35218 2/20 0.59
▸ CA7 P43166 2/20 0.59
▸ CA9 Q16790 2/20 0.59
▸ CA14 Q9ULX7 2/20 0.59
▸ CA5B Q9Y2D0 2/20 0.59
▸ KDM4E B2RXH2 1/20 0.59
▸ CA1 P00915 1/20 0.59
▸ CA2 P00918 1/20 0.59
▸ CA3 P07451 1/20 0.59
▸ PKM P14618 1/20 0.59
▸ CSNK2A2 P19784 1/20 0.59
▸ SNCA P37840 1/20 0.59
▸ CSNK2B P67870 1/20 0.59
▸ CSNK2A1 P68400 1/20 0.59
▸ CSNK2A3 Q8NEV1 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoeugenol SCHEMBL3699102 1.00 TYR (0.81) TYRTTRCA12CA4CA6
Isoeugenol SCHEMBL2686818 0.92 TYR (0.84) TYRTTRCA12CA4CA6
Cis/Trans-Isoeugenol SCHEMBL2686822 0.92 TYR (0.84) TYRTTRCA12CA4CA6
Isoeugenol SCHEMBL29369838 0.90 TYR (1.00) TYRTTRCA12CA4CA6
Isoeugenol SCHEMBL2463281 0.90 TYR (1.00) TYRTTRCA12CA4CA6
Isoeugenol SCHEMBL300766 0.90 TYR (1.00) TYRTTRCA12CA4CA6
Cis/Trans-Isoeugenol SCHEMBL57987 0.90 TYR (1.00) TYRTTRCA12CA4CA6
Cis/Trans-Isoeugenol SCHEMBL29361918 0.90 TYR (1.00) TYRTTRCA12CA4CA6
Isoeugenol SCHEMBL57986 0.90 TYR (1.00) TYRTTRCA12CA4CA6
Cis/Trans-Isoeugenol SCHEMBL2463283 0.90 TYR (1.00) TYRTTRCA12CA4CA6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013134220-A1 ELECTROCATALYTIC HYDROGENATION AND HYDRODEOXYGENATION OF OXYGENATED AND UNSATURATED ORGANIC COMPOUNDS BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2013-09-12 — — WO disclosed
US-20120123155-A1 BIOCATALYST FOR CATALYTIC HYDROAMINATION BASF SE (DE) 2012-05-17 — — US disclosed
EP-1928992-A1 CONSUMER PRODUCTS HAVING VARYING ODORS Henkel AG & Co. KGaA (DE) 2008-06-11 — — EP disclosed
WO-2007028479-A1 CONSUMER PRODUCTS HAVING VARYING ODORS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-03-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123155-A1 BIOCATALYST FOR CATALYTIC HYDROAMINATION HDHD5, PAH, GRHPR TYR 27/4885TTR 1251/4885CA12 2675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback